Assessment of the Chemosensitizing Activity of TAT-RasGAP(317-326) in Childhood Cancers

Although current anti-cancer protocols are reasonably effective, treatment-associated long-term side effects, induced by lack of specificity of the anti-cancer procedures, remain a challenging problem in pediatric oncology. TAT-RasGAP(317-326) is a RasGAP-derived cell-permeable peptide that acts as...

Descripción completa

Detalles Bibliográficos
Autores principales: Chevalier, Nadja, Gross, Nicole, Widmann, Christian
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2015
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4380404/
https://www.ncbi.nlm.nih.gov/pubmed/25826368
http://dx.doi.org/10.1371/journal.pone.0120487

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4380404/
https://www.ncbi.nlm.nih.gov/pubmed/25826368
http://dx.doi.org/10.1371/journal.pone.0120487

Ejemplares similares